Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Leukemia|September 23, 2006
High leucovorin doses during high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemiaT V Ch Skärby, H Anderson, J Heldrup, et al.
Gene Therapy|July 6, 2007
Utility of TK/GCV in the context of highly effective oncolysis mediated by a serotype 3 receptor targeted oncolytic adenovirusM Raki, T Hakkarainen, G J Bauerschmitz, et al.
Gene Therapy|April 11, 2008
Changing the adenovirus fiber for retaining gene delivery efficacy in the presence of neutralizing antibodiesM Särkioja, S Pesonen, M Raki, et al.
Gene Therapy|May 15, 2009
Ad5/3-9HIF-Delta24-VEGFR-1-Ig, an infectivity enhanced, dual-targeted and antiangiogenic oncolytic adenovirus for kidney cancer treatmentK Guse, I Diaconu, M Rajecki, et al.
Acta Paediatrica (Oslo, Norway : 1992)|July 28, 2019
Incidence and long-term outcomes of surgically treated childhood hepatic malignancies in FinlandToivo Tiusanen, Maria Hukkinen, Outi Leskinen, et al.
Gene Therapy|April 1, 2005
Combination of gemcitabine and Ad5/3-Delta24, a tropism modified conditionally replicating adenovirus, for the treatment of ovarian cancerM Raki, A Kanerva, A Ristimaki, et al.
Gene Therapy|August 11, 2006
A heparan sulfate-targeted conditionally replicative adenovirus, Ad5.pk7-Delta24, for the treatment of advanced breast cancerT Ranki, A Kanerva, A Ristimäki, et al.
Oncoimmunology|May 4, 2018
TNFa and IL-2 armed adenoviruses enable complete responses by anti-PD-1 checkpoint blockadeV Cervera-Carrascon, M Siurala, J M Santos, et al.
Gene Therapy|March 5, 2004
A cyclooxygenase-2 promoter-based conditionally replicating adenovirus with enhanced infectivity for treatment of ovarian adenocarcinomaA Kanerva, G J Bauerschmitz, M Yamamoto, et al.
Cancer Gene Therapy|January 20, 2007
A three-dimensional assay for measurement of viral-induced oncolysisJ T Lam, A Hemminki, A Kanerva, et al.
Pageof 3